Clinical trial

Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLC

NCT04629027

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2021-03-03

PhaseN/A

Study timeline

Study start (estimated)2021-03-03Date precision: day

Registry last updated2021-02-24

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non Small Cell Lung Cancerunresolved

Interventions

Immune checkpoint inhibitorDRUG

Sponsors & collaborators

Peking University Cancer Hospital & Institutelead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04629027 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.